FDA Report On Its 50 Years In Cannabis Research, Signals A Boost In Medical Marijuana Prospects - Jazz Pharmaceuticals (NASDAQ:JAZZ)
Researchers with the Food and Drug Administration (FDA) reported Wednesday on the agency’s 50 years of experience with marijuana research. In an article titled “FDA’s 50
Source: benzinga.com